JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Usmani, O. S.
Right arrow Articles by Barnes, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Usmani, O. S.
Right arrow Articles by Barnes, P. J.
Journal of Nuclear Medicine Vol. 45 No. 1 69-73
© 2004 by Society of Nuclear Medicine


Brief Communications

Characterization of the Generation of Radiolabeled Monodisperse Albuterol Particles Using the Spinning-Top Aerosol Generator

Omar S. Usmani, MB BS1, Martyn F. Biddiscombe, PhD2, S. Richard Underwood, MD2 and Peter J. Barnes, MD1

1 Department of Thoracic Medicine, National Heart and Lung Institute, Imperial College London, London, United Kingdom
2 Department of Nuclear Medicine, Royal Brompton Hospital, London, United Kingdom

ABSTRACT

Inhaled radiolabeled aerosols provide invaluable information about in vivo drug deposition. Here, we report our methodology for radiolabeling and imaging monodisperse pharmacologic aerosols in order to study basic aerosol science concepts of drug delivery within the human airways. Methods: We used a spinning-top aerosol generator to produce 99mTc-labeled monodisperse albuterol sulfate aerosols of 1.5-, 3-, and 6-µm mass median aerodynamic diameter. Results: In vitro Andersen cascade validation data showed that technetium and albuterol were coassociated on each impactor stage for all 3 aerosols, and the radiolabeling process itself did not affect their particle size distributions. Good-quality {gamma}-camera scintigraphic images of lung and extrathoracic deposition were obtained within an asthmatic patient. Conclusion: We have successfully radiolabeled and imaged monodisperse albuterol aerosols within the human lungs. This novel technique provides an important tool to relate fundamental concepts of aerosol particle behavior, in vivo deposition, and therapeutic clinical response.

Key Words: lung aerosol deposition • ß2-agonist • particle size • planar scintigraphy




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
O. S. Usmani, M. F. Biddiscombe, and P. J. Barnes
Regional Lung Deposition and Bronchodilator Response as a Function of {beta}2-Agonist Particle Size
Am. J. Respir. Crit. Care Med., December 15, 2005; 172(12): 1497 - 1504.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2004 by the Society of Nuclear Medicine.